Kathryn E. Yost

7.4k total citations · 3 hit papers
21 papers, 2.3k citations indexed

About

Kathryn E. Yost is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Kathryn E. Yost has authored 21 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Immunology. Recurrent topics in Kathryn E. Yost's work include CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (7 papers) and T-cell and B-cell Immunology (6 papers). Kathryn E. Yost is often cited by papers focused on CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (7 papers) and T-cell and B-cell Immunology (6 papers). Kathryn E. Yost collaborates with scholars based in United States, Germany and Australia. Kathryn E. Yost's co-authors include Howard Y. Chang, Ansuman T. Satpathy, Daniel K. Wells, Christina Curtis, Yanyan Qi, Kavita Y. Sarin, Jeffrey M. Granja, Anne Lynn S. Chang, Mark M. Davis and Rohit Gupta and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Kathryn E. Yost

21 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clonal replacement of tumor-specific T cells following PD-1 blockade

2019 876 citations Kathryn E. Yost, Ansuman T. Satpathy et al. Nature Medicine profile →
Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen

2020 343 citations Santosha A. Vardhana, Madeline A. Hwee et al. Nature Immunology profile →
Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence

2022 201 citations Julia A. Belk, Winnie Yao et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathryn E. Yost United States	15	1.1k	1.1k	1.1k	444	155	21	2.3k
Jai Rautela Australia	19	1.0k 0.9×	1.3k 1.2×	648 0.6×	226 0.5×	124 0.8×	31	2.1k
Robert T. Manguso United States	12	1.0k 0.9×	949 0.8×	891 0.8×	203 0.5×	96 0.6×	19	1.9k
Lynne Collins United States	16	1.1k 1.0×	1.4k 1.2×	741 0.7×	199 0.4×	100 0.6×	21	2.4k
Karen Clise-Dwyer United States	23	781 0.7×	1.1k 1.0×	795 0.7×	359 0.8×	95 0.6×	54	2.2k
Hyun-Il Cho United States	15	1.1k 0.9×	1.7k 1.5×	506 0.5×	312 0.7×	159 1.0×	15	2.2k
Bihui Xu United States	5	950 0.8×	924 0.8×	872 0.8×	537 1.2×	69 0.4×	5	1.9k
Kyle K. Payne United States	22	699 0.6×	765 0.7×	544 0.5×	227 0.5×	109 0.7×	42	1.5k
Katelyn T. Byrne United States	19	1.5k 1.3×	1.5k 1.3×	506 0.5×	234 0.5×	119 0.8×	30	2.4k
Natalie B. Collins United States	10	963 0.8×	826 0.7×	775 0.7×	189 0.4×	71 0.5×	21	1.7k
Joseph Cursons Australia	18	744 0.6×	808 0.7×	696 0.6×	291 0.7×	90 0.6×	32	1.6k

Countries citing papers authored by Kathryn E. Yost

Since Specialization

Citations

This map shows the geographic impact of Kathryn E. Yost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn E. Yost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn E. Yost more than expected).

Fields of papers citing papers by Kathryn E. Yost

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn E. Yost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn E. Yost. The network helps show where Kathryn E. Yost may publish in the future.

Co-authorship network of co-authors of Kathryn E. Yost

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn E. Yost. A scholar is included among the top collaborators of Kathryn E. Yost based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn E. Yost. Kathryn E. Yost is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koblan, Luke W., Kathryn E. Yost, Pu Zheng, et al.. (2025). High-resolution spatial mapping of cell state and lineage dynamics in vivo with PEtracer. Science. 390(6770). eadx3800–eadx3800. 3 indexed citations

Rose, John C., Julia A. Belk, Ivy Tsz-Lo Wong, et al.. (2024). Disparate Pathways for Extrachromosomal DNA Biogenesis and Genomic DNA Repair. Cancer Discovery. 15(1). 69–82. 10 indexed citations

Buquicchio, Frank A., Raíssa Fonseca, Patrick Yan, et al.. (2024). Distinct epigenomic landscapes underlie tissue-specific memory T cell differentiation. Immunity. 57(9). 2202–2215.e6. 16 indexed citations

Wheeler, Joshua, Oscar N. Whitney, Thomas O. Vogler, et al.. (2022). RNA-binding proteins direct myogenic cell fate decisions. eLife. 11. 15 indexed citations

Dániel, Bence, Kathryn E. Yost, Sunnie Hsiung, et al.. (2022). Divergent clonal differentiation trajectories of T cell exhaustion. Nature Immunology. 23(11). 1614–1627. 97 indexed citations

Yu, Bingfei, Quanming Shi, Julia A. Belk, et al.. (2022). Engineered cell entry links receptor biology with single-cell genomics. Cell. 185(26). 4904–4920.e22. 40 indexed citations

Belk, Julia A., Winnie Yao, Nghi Ly, et al.. (2022). Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence. Cancer Cell. 40(7). 768–786.e7. 201 indexed citations breakdown →

Wu, Kevin, Kathryn E. Yost, Howard Y. Chang, & James Zou. (2021). BABEL enables cross-modality translation between multiomic profiles at single-cell resolution. Proceedings of the National Academy of Sciences. 118(15). 74 indexed citations

Maas‐Bauer, Kristina, Juliane K. Lohmeyer, Toshihito Hirai, et al.. (2021). Invariant natural killer T-cell subsets have diverse graft-versus-host-disease–preventing and antitumor effects. Blood. 138(10). 858–870. 20 indexed citations

10.

Foster, Deshka S., Michael Januszyk, Kathryn E. Yost, et al.. (2021). Cancer-Associated Fibroblasts Share Highly Conserved Phenotypes and Functions Across Tumor Types and Species. Journal of the American College of Surgeons. 233(5). S243–S244. 1 indexed citations

11.

Yost, Kathryn E., Howard Y. Chang, & Ansuman T. Satpathy. (2021). Recruiting T cells in cancer immunotherapy. Science. 372(6538). 130–131. 69 indexed citations

12.

Vardhana, Santosha A., Madeline A. Hwee, Mirela Berisa, et al.. (2020). Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen. Nature Immunology. 21(9). 1022–1033. 343 indexed citations breakdown →

13.

Carter, Ava C., Jin Xu, Yuning Wei, et al.. (2020). Spen links RNA-mediated endogenous retrovirus silencing and X chromosome inactivation. eLife. 9. 37 indexed citations

14.

Yost, Kathryn E., Howard Y. Chang, & Ansuman T. Satpathy. (2019). Tracking the immune response with single-cell genomics. Vaccine. 38(28). 4487–4490. 6 indexed citations

15.

Yost, Kathryn E., Ansuman T. Satpathy, Daniel K. Wells, et al.. (2019). Clonal replacement of tumor-specific T cells following PD-1 blockade. Nature Medicine. 25(8). 1251–1259. 876 indexed citations breakdown →

16.

Yost, Kathryn E., Sarah F. Clatterbuck Soper, Robert L. Walker, et al.. (2019). Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells. Scientific Reports. 9(1). 4544–4544. 34 indexed citations

17.

Chang, Anne Lynn S., Duy Tran, Shufeng Li, et al.. (2018). Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study. Journal of the American Academy of Dermatology. 80(2). 564–566. 78 indexed citations

18.

Cho, Seung Woo, Jin Xu, Ruping Sun, et al.. (2018). Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element. Cell. 173(6). 1398–1412.e22. 313 indexed citations

19.

Yost, Kathryn E., Ava C. Carter, Jin Xu, Ulrike Litzenburger, & Howard Y. Chang. (2018). ATAC Primer Tool for targeted analysis of accessible chromatin. Nature Methods. 15(5). 304–305. 11 indexed citations

20.

Yost, Kathryn E.. (1983). The International Sea-Bed Authority Decision-Making Process: Does It Give a Proportionate Voice to the Participant's Interests in Deep Sea Mining?. San Diego law review. 20(3). 659. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact